By Editor • August 18, 2026 • 1 min read
Amylyx has announced positive results from a pivotal trial, demonstrating that its experimental drug effectively assists patients facing sudden blood sugar drops post-bariatric surgery.
Source: www.statnews.com
By Editor • August 18, 2026 • 1 min read
Major health care executives in Massachusetts saw significant salary increases in 2024 amid rising operational challenges.
Read moreBy Editor • August 18, 2026 • 1 min read
Government workers are facing intensified health care challenges as states approach a crucial deadline for a federal drug pricing program.
Read moreBy Editor • August 18, 2026 • 1 min read
Eyepoint's trial setback for Duravyu contrasts with Ocular Therapeutix's stock rise, while Novartis withdraws reimbursement plans for another new drug in Canada.
Read more
